We are the second largest university hospital in Norway. The investment in medical and health-related research and innovation is extensive. We have several cutting-edge research environments at a high international level, at the same time we believe that it is important to have breadth in research.
As a regional hospital with many specific functions and high competence, we have particular responsibility for conducting research-based patient treatment, education and training of health personnel.
Read our Sub-plan for Research and Innovation 2023-2026 (PDF)
Interested in research cooperation?
Research and innovation
- Cardiac markers
This research group is focused on clinical research concerning cardiac biomarkers and imaging.
- PROCARD
Despite decreases in mortality rates and improved treatment methods, 450,000 Norwegians live with chronic cardiovascular conditions that not only affect their daily life but also have implications for clinicians, healthcare systems and society at large. Patient-reported outcomes, together with clinical outcome measures, form the foundation for shared decision-making and are of special importance in cardiovascular clinical practice.
- Dried plasma
Helse Bergen has received 15 millions in funding from Innovation Norway to develop technology for local production of dried plasma. This technology is of interest both on an national and international level.
- Regenerative Medicine
In Mohn Research Centre for Regenerative Medicine (MRCRM), we aim to develop new cell-based therapies to repair or replace - to regenerate - tissues and cells damaged by disease or injury. Our research focus spans from biomedical to clinica...
- Bergen Center for Brain Plasticity
The mission of the Bergen Center for Brain Plasticity is use highly effective, concentrated treatment formats to elucidate multilevel mechanisms of brain plasticity to gain new insights of relevance for future therapies.
- Bergen Translational Cardiac Research Group
Dept. of Heart Disease Haukeland University Hospital